Skip to main content
SpringerLink
Log in

Over-the-Counter (OTC) Drugs and Some Prescription Drugs

  • Chapter
Drug and Alcohol Abuse

Part of the book series: Critical Issues in Psychiatry ((CIPS))

  • 378 Accesses

Abstract

Almost any substance has the potential for misuse (if we define this as the voluntary intake to the point of causing physical or psychological harm). As discussed in chapter 1, this potential is especially true if the drug alters an individual’s perception of his environment. In that context, this chapter presents data on the misuse of over-the-counter (OTC) medications and some prescription drugs, including the antiparkinsonian medications, diuretics, and antipsychotics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Covington, T. R., Lawson, L. C., & Young, L. L. (Eds.). Handbook of nonprescription drugs (10th ed.). Washington, DC: American Pharmaceutical Association, 1993.

    Google Scholar 

  2. Inciardi, J. A. Over-the-counter drugs: Epidemiology, adverse reactions, overdose deaths, and mass media promotion. Addictive Diseases: An International Journal 3:253–272, 1977.

    Google Scholar 

  3. Boatman, D. W., & Gagnon, J. P. The pharmacist as an information source for non-prescription drugs. Journal of Drug Issues 7:183–193, 1977.

    Google Scholar 

  4. Schuckit, M. A. Educating yourself about alcohol and drugs. New York: Plenum Publishing Co., 1998.

    Google Scholar 

  5. Kalish, S. C., Bohn, R. L., & Avorn, J. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use. Medical Care 35:32–48, 1997.

    Article  PubMed  Google Scholar 

  6. Blenkinsopp, A., & Bradley, C. Patients, society, and the increase in self medication. British Medical Journal 312:629–632, 1996.

    Article  PubMed  Google Scholar 

  7. Uhde, T. W., & Tancer, M. E. Antihistamines. In H. I. Kaplan & G. J. Saddock (Eds.), Comprehensive textbook of psychiatry (6th ed.). Baltimore, MD: Williams & Wilkins, 1995.

    Google Scholar 

  8. Lam, L. D. W., Lee, D. T. S., Shum, P. P. S., & Chen, D. N. Cough mixture misuse in Hong Kong—An emerging psychiatric problem? Addiction 91:1375–1378, 1996.

    PubMed  Google Scholar 

  9. Rickeis, K. Use of antianxiety agents in anxious outpatients. Psychopharmacology 58:1–17, 1978.

    Article  Google Scholar 

  10. Austin, K. F. Disease of immediate type hypersensitivity. In A. S. Fauci, E. Braunwald, K. J. Iselbacher, et al. (Eds.), Harrison’s principles of internal medicine (14th ed.). New York: McGraw-Hill, 1998, pp. 1860–1869.

    Google Scholar 

  11. Mattoo, S. K., Basu, D., Sharma, A., Balaji, M., & Malhotra, A. Abuse of codeine-containing cough syrups: A report from India. Addiction 92:1787–1793, 1997.

    Article  Google Scholar 

  12. Babe, K. S., & Serafin, W. E. Histamine, bradykinen, and their antagonists. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 581–600.

    Google Scholar 

  13. Bassett, K. E., Schunk, J. E., & Crouch, B. I. Cyclizine abuse by teenagers in Utah. American Journal of Emergency Medicine 14:472–474, 1996.

    Article  PubMed  Google Scholar 

  14. Hill, S. J. Histamine receptor agonists and antagonists. Neurotransmissions 8(1):1–5, 1992.

    Google Scholar 

  15. Lijinsky, W. Liver tumor induced in rats by oral administration of an antihistamine. Science 209:817–818, 1980.

    Article  PubMed  Google Scholar 

  16. Bryant, B. G., & Lombardi, T. P. Cold and allergy products. In American Pharmaceutical Association Project Staff (Eds.), Handbook of nonprescription drugs (9th ed.). Washington, DC: American Pharmaceutical Association, 1990, pp. 133–205.

    Google Scholar 

  17. Hoffman, B. B., & Lefkowitz, R. J. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 199–248.

    Google Scholar 

  18. Gauvin, D. V., Vanecek, S. A., Baird, T. J., et al. The stimulus properties of two common over-the-counter drug mixtures: dextromethorphan + ephedrine and dextromethorphan + diphenhydramine. Journal of Psychopharmacology 12:84–92, 1998.

    Article  PubMed  Google Scholar 

  19. Roberge, R. J., Hirani, K. H., Rowland, P. L., III, et al. Dextromethorphan-and pseudophedrine-induced agitated psychosis and ataxia: case report. Journal of Emergency Medicine 17:285–288, 1999.

    Article  PubMed  Google Scholar 

  20. Serofin, W. E. Drugs used in the treatment of asthma. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 659–683.

    Google Scholar 

  21. Tempesta, E., Janiri, L., Mannelli, P., et al. Clinical reports on recent abuse of an antitussive. British Journal of Addiction 85:815–816, 1990.

    Article  PubMed  Google Scholar 

  22. Bisaga, A., Gianelli, P., & Popik, P. Opiate withdrawal with dextromethorphan. American Journal of Psychiatry 154:584, 1997.

    PubMed  Google Scholar 

  23. Insel, P. A. Analgesic-antipyretic and antiflammatory agents and drugs employed in the treatment of gout. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 617–657.

    Google Scholar 

  24. Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. Risk of Alzheimer’s disease and duration of NSAID use. Neurology 48:626–632, 1997.

    Article  PubMed  Google Scholar 

  25. Fourrier, A., Letenneur, L., Bégaud, D., & Dartigues, J. F. Nonsteroidal anti-inflammatory drug use and cognitive function in the elderly: Inconclusive results from a population-based cohort study. Journal of Clinical Epidemiology 49:1201, 1996.

    Article  PubMed  Google Scholar 

  26. Dubach, U. C., Rosner, B., & Pfister, E. Epidemiologic study of abuse of analgesics containing phenacetin. New England Journal of Medicine 308:357–362, 1983.

    Article  PubMed  Google Scholar 

  27. Bach, P. H., Berndt, W O., Delzell, E., et al. A safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine. Renal Failure 20:749–762, 1998.

    Article  PubMed  Google Scholar 

  28. Pommer, W., Bronder, E., Offerman, G., et al. Analgesic consumption and analgesic-associated nephropathy: Extent, prevalence, and costs: Data from the Federal Republic of Germany and Berlin (West). Muenchener Medizinische Wochenschrift 128:220–223, 1986.

    Google Scholar 

  29. Browning, C. H. Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects. International Journal of Psychiatry in Medicine 26:25–34, 1996.

    Article  PubMed  Google Scholar 

  30. Zimmerman, J. J., & Maddrey, W. C. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology 22:767–773, 1995.

    Article  PubMed  Google Scholar 

  31. Brunton, L. L. Agents for control of gastric acidity and treatment of peptic ulcers. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 901–915.

    Google Scholar 

  32. Bulik, C. M., Epstein, L. H., & Kaye, W. Treatment of laxative abuse in a female with bulimia nervosa using an operant extinction paradigm. Journal of Substance Abuse 2:381–388, 1990.

    Article  PubMed  Google Scholar 

  33. Curry, C. E., & Tatum-Butler, D. Laxative products. In T. R. Covington, L. C. Lawson, & L. L. Young (Eds.), Handbook of nonprescription drugs (10th ed.). Washington, DC: American Pharmaceutical Association, 1993, pp. 219–236.

    Google Scholar 

  34. Bulik, C. M. Abuse of drugs associated with eating disorders. Journal of Substance Abuse 4:69–90, 1992.

    Article  PubMed  Google Scholar 

  35. Greden, J. F., & Pomerleau, O. Caffeine-related disorders and nicotine-related disorders. In H. I. Kaplan & D. J. Saddock (Eds.), Comprehensive textbook of psychiatry (6th ed.). Baltimore, MD: Williams & Wilkins, 1995.

    Google Scholar 

  36. Crismon, M. L., & Jermain, D. M. Stimulant products. In T. R. Covington, L. C. Lawson, & L. L. Young (Eds.), Handbook of nonprescription drugs (10th ed.). Washington, DC: American Pharmaceutical Association, 1993, pp. 141–146.

    Google Scholar 

  37. Hobbs, D., & Chawkins, S. Natural causes ruled out in death of Fillmore girl. Los Angeles Times pg. A-21, April 18, 1998.

    Google Scholar 

  38. Griffeths, P., & Gossap, M. A transcellular pattern of drug use: Khat. British Journal of Psychiatry 170:281–284, 1997.

    Article  Google Scholar 

  39. Stevenson, M., Fitzgerald, J., & Banwell, C. Chewing as a social act: Cultural displacement and ‘khat’ consumption in the East African communities of Melbourne. Drug and Alcohol Review 15:73–82, 1996.

    Article  PubMed  Google Scholar 

  40. Lake, C. R. Manic psychosis after coffee and phenylpropanolamine. Biological Psychiatry 30:401–404, 1991.

    Article  PubMed  Google Scholar 

  41. Whitehouse, A. Ephedrine psychosis rediscovered. British Journal of Psychiatry 150:258–261, 1987.

    Article  PubMed  Google Scholar 

  42. Ryu, S. J., & Lin, S. K. Cerebral arteritis associated with oral use of phenylpropanolamine: report of a case. Journal of the Formosan Medical Association 94:53–55, 1995.

    PubMed  Google Scholar 

  43. Reeves, R. R., Carter, O. S., Pinkofsky, H. B., et al. Carisoprodol (soma): abuse potential and physician un-awareness. Journal of Addictive Diseases 18:51–56, 1999.

    Article  PubMed  Google Scholar 

  44. Boyd, A. Bromocriptine and psychosis: a literature review. Psychiatric Quarterly 66:87–95, 1995

    Article  PubMed  Google Scholar 

  45. Ross, R. G., & Ward, N. G. Bromocriptine abuse. Biological Psychiatry 31:404–406, 1992.

    Article  PubMed  Google Scholar 

  46. Goodwin, D. W., & Guze, S. B. Psychiatric diagnosis (5th ed.). New York: Oxford University Press, 1996.

    Google Scholar 

  47. American Psychiatric Association. The diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press, 1994.

    Google Scholar 

  48. Schuckit, M. A., Tipp, J. E., Bucholz, K. K., et al. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholic and controls. Addiction 92:1289–1304, 1997.

    Article  PubMed  Google Scholar 

  49. Schuckit, M. A. Alcohol, anxiety, and depressive disorders. Alcohol Health & Research World 20:81–85, 1996.

    Google Scholar 

  50. Schuckit, M. A., Tipp, J. E., Bergman, M., et al. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. American Journal of Psychiatry 154:948–957, 1997.

    PubMed  Google Scholar 

  51. Schuckit, M. A. Clinical aspects of the use of antidepressant medications in persons with developmental disabilities. Developmental Disabilities: Clinical Insights 4, San Diego Regional Center for the Developmentally Disabled, 1998.

    Google Scholar 

  52. Raimo, E. B., & Schuckit, M. A. Alcohol dependence and mood disorders. Addictive Behaviors 23:933–946, 1998.

    Article  PubMed  Google Scholar 

  53. Baumbacher, G., & Hansen, M. S. Abuse of monoamine oxidase inhibitors. American Journal of Alcohol Abuse 18:399–406, 1992.

    Article  Google Scholar 

  54. Schuckit, M. A. Clinical aspects of the use of antipsychotic medication in persons with developmental disabilities. Developmental Disabilities: Clinical Insights 3, San Diego Regional Center for the Developmentally Disabled, 1998.

    Google Scholar 

  55. Schuckit, M. A. The diagnosis and pharmacological treatment of anxiety disorders in persons with developmental disabilities. Developmental Disabilities: Clinical Insights 5, San Diego Regional Center for the Developmentally Disabled, 1998.

    Google Scholar 

  56. Gao, Z. G., Liu, B. Y., Cui, W. Y., et al. Anti-nicotinic properties of anticholinergic antiparkinson drugs. Journal of Pharmacy and Pharmacology 50:1299–1305, 1998.

    Article  PubMed  Google Scholar 

  57. Standaert, D. G., & Young, A. B. Treatment of central nervous system degenerative disorders. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 503–519.

    Google Scholar 

  58. Zemishlany, Z., Aizenberg, D., Weiner, Z., & Weizman, A. Trihexyphenidyl (Artane) abuse in schizophrenic patients. International Clinical Psychopharmacology 11:199–202, 1996.

    Article  PubMed  Google Scholar 

  59. König, P., Chwatal, K., Havelec, L., et al. Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders. Neuropsychobiology 33:80–84, 1996.

    Article  PubMed  Google Scholar 

  60. Pullen, G. P., Best, N. R., & Maguire, J. Anticholingeric drug abuse: A common problem? British Medical Journal 289:612–613, 1984.

    Article  PubMed  Google Scholar 

  61. Sennhauser, F. H., & Schwarz, H. P. Toxic psychosis from transdermal scopolamine in a child. Lancet 2:1033, 1986.

    Article  PubMed  Google Scholar 

  62. Brown, J. H., & Taylor, P. Muscarinic receptor agonists and antagonists. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 141–160.

    Google Scholar 

  63. Galloway, G. P. Anabolic-androgenic steroids. In J. H. Lowinson, P. Ruiz, R. B. Millman, J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996.

    Google Scholar 

  64. Beel, A., Maycock, B., & McLean, N. Current perspectives on anabolic steroids. Drug and Alcohol Review 17:87–103, 1998.

    Article  PubMed  Google Scholar 

  65. Pope, H. G., & Katz, D. L. Psychiatric and medical effects of anabolic-androgenic steroid use: A controlled study of 160 athletes. Archives of General Psychiatry 51:375–382, 1994.

    Article  PubMed  Google Scholar 

  66. Wilson, J. D. Androgens. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 1441–1457.

    Google Scholar 

  67. Bardin, D. W The anabolic action of testosterone. New England Journal of Medicine 335:52–53, 1996.

    Article  PubMed  Google Scholar 

  68. Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. The effects of supraphysiologic dose of testosterone on muscle size and strength in normal men. New England Journal of Medicine 335:1–7, 1996.

    Article  PubMed  Google Scholar 

  69. Kindlundh, A. M. S., Isacson, D. G. L., Berglund, L., & Nyberg, F. Factors associated with adolescent use of doping agents: anabolic-androgenic streoids. Addiction 94:543–553, 1999.

    Article  PubMed  Google Scholar 

  70. Johnston, L. D., O’Malley, P. M., & Bachman, J. G. National survey results on drug use from the Monitoring the Future Study, 1975–1997, Vol. I, Secondary School Students. Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services, 1998.

    Google Scholar 

  71. Meilman, P. W., Crace, R. K., Presley, C. A., & Lyerla, R. Beyond performance enhancement: Polypharmacy among collegiate users of steroids. Journal of American College Health 44:98–104, 1995.

    Article  PubMed  Google Scholar 

  72. Brower, K. J., Eliopulos, G. A., Blow, F. C., et al. Evidence for physical and psychological dependence on anabolic-androgenic steroids in eight weight lifters. American Journal of Psychiatry 147:510–512, 1990.

    PubMed  Google Scholar 

  73. Lukas, S. E. The pharmacology of steroids. In A. W. Graham, T. K. Schultz, & B. B. Wilford (Eds.). Principles of addiction medicine (2nd ed.). Chevy Chase, MD: American Society of Addiction Medicine, 1998, pp. 173–186.

    Google Scholar 

  74. Yates, W. R., Perry, P., & Murray, S. Aggression and hostility in anabolic steroid users. Biological Psychiatry 31:1232–1234, 1992.

    Article  PubMed  Google Scholar 

  75. Choi, P. Y. L., & Pope, H. G., Jr. Violence toward women and illicit androgenic-anabolic steroid use. Annals of Clinical Psychiatry 6:21–25, 1994.

    Article  PubMed  Google Scholar 

  76. Ellingrod, V. L., Perry, P. J., Yates, W. R., MacIndoe, J. H., Watson, G., Arndt, S., & Holman, T. L. The effects of anabolic steroids on driving performance as assessed by the Iowa driver simulator. American Journal of Drug and Alcohol Abuse 23:623–636, 1997.

    Article  PubMed  Google Scholar 

  77. Driessen, M., Muessigbrodt, H., Dilling, H., & Driessen, B., Child sexual abuse associated with anabolic androgenic steroid use. American Journal of Psychiatry 153:1369, 1996.

    PubMed  Google Scholar 

  78. Council on Scientific Affairs. Medical and nonmedial use of anabolic-androgenic steroids. Journal of the American Medical Association 264:2923–2927, 1990.

    Article  Google Scholar 

  79. Perry, P. J., Yates, W. R., & Anderson, K. H. Psychiatric symptoms associated with anabolic steroids: A controlled, retrospective study. Annals of Clinical Psychiatry 2:11–17, 1990.

    Article  Google Scholar 

  80. Yates, W. R., Perry, P. J. Maclndoe, J., et al. Psychosexual effects of three doses of testosterone cycling in normal men. Biological Psychiatry 45:254–260, 1999.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California Medical School and Veterans Affairs San Diego Healthcare System, San Diego, California, USA

    Marc A. Schuckit M. D. (Professor of Psychiatry)

Authors
  1. Marc A. Schuckit M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schuckit, M.A. (2000). Over-the-Counter (OTC) Drugs and Some Prescription Drugs. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3232-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3232-0_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-3234-4

  • Online ISBN: 978-1-4757-3232-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation